Initial clinical use of the intraocular endoscope holding robot in pars plana vitrectomy.

IF 1.9 3区医学 Q2 OPHTHALMOLOGY

Japanese Journal of Ophthalmology Pub Date : 2025-10-03 DOI:10.1007/s10384-025-01285-1

Kohei Kiyohara, Keijiro Ishikawa, Kodai Yuge, Satoshi Yamana, Shintaro Nakao, Koh-Hei Sonoda

{"title":"Initial clinical use of the intraocular endoscope holding robot in pars plana vitrectomy.","authors":"Kohei Kiyohara, Keijiro Ishikawa, Kodai Yuge, Satoshi Yamana, Shintaro Nakao, Koh-Hei Sonoda","doi":"10.1007/s10384-025-01285-1","DOIUrl":null,"url":null,"abstract":"Purpose: OQrimo® is a robotic assistant system that supports vitreoretinal surgery by holding an intraocular endoscope or illumination device to assist the surgeon. In April 2023, Japan approved this system, and as the world's first clinical institution to implement OQrimo®, we aimed to evaluate its safety and clinical utility.Research design: Retrospective case series METHODS: The study analyzed all vitreoretinal surgery utilizing OQrimo® at Kyushu University Hospital between December 1, 2023 and November 31, 2024. Data collection included patient demographics, preoperative diagnoses, surgical procedures, equipment used, surgical records, and perioperative complications. We analyzed OQrimo's safety profile and patterns of clinical use based on these data.Results: Eight eyes from eight patients were included. Preoperative diagnoses included proliferative vitreoretinopathy, panuveitis, acute retinal necrosis, macular hole, and secondary glaucoma due to uveitis. The purpose of pars plana vitrectomy included silicone oil removal, vitreous biopsy, internal limiting membrane peeling, and Ahmed valve implantation via pars plana. OQrimo® maintained stable endoscope positioning in all cases, enabling observation of the peripheral retina without scleral indentation. In seven cases, OQrimo's endoscopic visualization and a wide-viewing system were used simultaneously. No intraoperative or postoperative complications were observed in any case.Conclusion: We confirmed the safety of OQrimo® during its initial clinical application. The system facilitated the observation of the peripheral retina using an intraocular endoscope without scleral indentation.","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10384-025-01285-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: OQrimo^® is a robotic assistant system that supports vitreoretinal surgery by holding an intraocular endoscope or illumination device to assist the surgeon. In April 2023, Japan approved this system, and as the world's first clinical institution to implement OQrimo^®, we aimed to evaluate its safety and clinical utility.

Research design: Retrospective case series METHODS: The study analyzed all vitreoretinal surgery utilizing OQrimo^® at Kyushu University Hospital between December 1, 2023 and November 31, 2024. Data collection included patient demographics, preoperative diagnoses, surgical procedures, equipment used, surgical records, and perioperative complications. We analyzed OQrimo's safety profile and patterns of clinical use based on these data.

Results: Eight eyes from eight patients were included. Preoperative diagnoses included proliferative vitreoretinopathy, panuveitis, acute retinal necrosis, macular hole, and secondary glaucoma due to uveitis. The purpose of pars plana vitrectomy included silicone oil removal, vitreous biopsy, internal limiting membrane peeling, and Ahmed valve implantation via pars plana. OQrimo^® maintained stable endoscope positioning in all cases, enabling observation of the peripheral retina without scleral indentation. In seven cases, OQrimo's endoscopic visualization and a wide-viewing system were used simultaneously. No intraoperative or postoperative complications were observed in any case.

Conclusion: We confirmed the safety of OQrimo^® during its initial clinical application. The system facilitated the observation of the peripheral retina using an intraocular endoscope without scleral indentation.

查看原文本刊更多论文

眼内内窥镜固定式机器人在玻璃体切割术中的初步临床应用。

OQrimo®是一种机器人辅助系统，通过手持眼内内窥镜或照明设备来辅助外科医生，支持玻璃体视网膜手术。2023年4月，日本批准了该系统，作为世界上第一个实施OQrimo®的临床机构，我们旨在评估其安全性和临床实用性。方法：本研究分析了2023年12月1日至2024年11月31日在九州大学医院使用OQrimo®进行的所有玻璃体视网膜手术。数据收集包括患者人口统计、术前诊断、手术程序、使用的设备、手术记录和围手术期并发症。基于这些数据，我们分析了OQrimo的安全性和临床使用模式。结果：纳入8例患者的8只眼。术前诊断包括增殖性玻璃体视网膜病变、全葡萄膜炎、急性视网膜坏死、黄斑孔和葡萄膜炎引起的继发性青光眼。玻璃体平部切除术的目的包括硅油去除、玻璃体活检、内限制膜剥离、经平部置入术。OQrimo®在所有病例中保持稳定的内窥镜定位，使观察周围视网膜无巩膜压痕。在7例中，OQrimo的内窥镜可视化和宽视野系统同时使用。无术中、术后并发症。结论：我们在OQrimo®的初步临床应用中证实了其安全性。该系统便于使用无巩膜压痕的眼内内窥镜观察周围视网膜。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Japanese Journal of Ophthalmology 医学-眼科学

CiteScore

4.80

自引率

8.30%

发文量

审稿时长

6-12 weeks

期刊介绍： The Japanese Journal of Ophthalmology (JJO) was inaugurated in 1957 as a quarterly journal published in English by the Ophthalmology Department of the University of Tokyo, with the aim of disseminating the achievements of Japanese ophthalmologists worldwide. JJO remains the only Japanese ophthalmology journal published in English. In 1997, the Japanese Ophthalmological Society assumed the responsibility for publishing the Japanese Journal of Ophthalmology as its official English-language publication. Currently the journal is published bimonthly and accepts papers from authors worldwide. JJO has become an international interdisciplinary forum for the publication of basic science and clinical research papers.